SILCSBIO LLC
Baltimore, MD · Biotech · Private
SILCS computational platform for protein formulation optimization using molecular dynamics simulation to predict excipient-protein interactions and stabilize biologic therapeutics
silcsbio.com →- Grants
- $7.2M
- 12 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142016201820202022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Pre-computed free energy maps for rapid structure-based ligand design | $157,155 | |
| Federal grant | Department of Health and Human Services · Phase I · Pre-computed free energy maps for rapid structure-based ligand design | $76,725 | |
| Federal grant | Department of Health and Human Services · Phase II · Pre-computed free energy maps for rapid structure-based ligand design | $326,846 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Pre-computed free energy maps for rapid structure-based ligand design | $403,571 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Pre-computed free energy maps for rapid structure-based ligand design | $1,287,608 | |
| Federal grant | Department of Health and Human Services · Phase II · Pre-computed free energy maps for rapid structure-based ligand design | $641,252 | |
| Federal grant | Department of Health and Human Services · Phase II · Pre-computed free energy maps for rapid structure-based ligand design | $319,510 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Computational Methods for Optimizing Biologics Formulation | $225,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Computational Methods for Optimizing Biologics Formulation | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Computational methods for optimized biologics formulation | $885,774 | |
| Federal grant | Department of Health and Human Services · Phase II · Computational methods for optimized biologics formulation | $1,753,242 | |
| Federal grant | Department of Health and Human Services · Phase II · Computational methods for optimized biologics formulation | $867,468 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2188 | Platform Therapeutics, Inc. | — | $1.8M |
| 2189 | Ceapro Inc. | — | $7.7M |
| 2190 | GREENSTONE BIOSCIENCES, INC. | — | $10M |
| 2191 | SILCSBIO LLC | — | — |
| 2192 | Hemab Therapeutics | — | — |
| 2193 | Medosome Biotec, LLC | — | — |
| 2194 | ADVERTENT BIOTHERAPEUTICS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.